Amnis designs, manufactures and markets leading cell imaging instrumentation for the research and clinical markets. The Companyâs flagship product is the ImageStream system, which combines the speed and sensitivity of flow cytometry with the power of high resolution digital microscopy. As the only technology capable of imaging cells at high speed directly in bodily fluids, ImageStream enables unique, non-invasive diagnostic applications. These applications include residual disease detection via high throughput FISH, circulating endothelial cell and tumor cell analysis, and advanced automated hematology based on multi-color phenotyping combined with histochemical staining. The Company holds 39 issued US patents and has 55 pending patents covering applications, subsystems, and the ImageStream architecture for imaging both in flow and on substrates. In August 2011 it was announced that Billerica MA based life sciences materials and supplies company EMD Millipore had, acquired cell imaging instrumentation maker Amnis Corporation of Seattle for an undisclosed amount. At that time the smallr firm had 40 employees and reported $14M inannual sales. The companyâs technology used in flow cytometry applications in academic, biotech and pharmaceutical markets serving to boost EMD Milliporeâs product portfolio in flow cytometry, which officials at the time described in the release as an âattractive growth se
